Month: May 2026

What if treating prostate cancer didn't mean choosing between all-or-nothing surgery and a watchful waiting approach that leaves many men anxious? Focal therapy has emerged as a precision middle ground — and a new journal review offers the most thorough look yet at how it works, what it achieves, and which men are the best candidates. keep reading

Most men with radiation-recurrent prostate cancer once had few good options — hormone therapy delayed the disease but offered no hope of cure. Today, focal salvage ablation is changing that picture. Now, a global expert panel has outlined the clinical trial standards needed to put this promising treatment on solid scientific footing. keep reading

In a murder mystery, the killer is often hiding in plain sight. The same can happen with prostate cancer. In 10-15% of cases that appear low risk, hidden aggressive disease is waiting for an unexpected twist. A deeper diagnostic workup—mpMRI, genomic analysis, and other tools—can reveal the true nature of the disease before a treatment plan is locked in. keep reading

Less than a third of men with a PSA result in the "gray zone" of 4–10 actually have prostate cancer. Yet for years, that number alone sent patients straight to biopsy. Today, mpMRI offers a smarter first step and a newly FDA-approved blood test called IsoPSA may be the safety net for cases MRI can't fully resolve. keep reading

Half of all men will deal with prostatitis at some point. The problem? Its symptoms — pelvic pain, urinary trouble, elevated PSA — can look almost identical to prostate cancer on standard tests. Before rushing to a biopsy, there's a better path: 3T multiparametric MRI can tell the difference with high accuracy and no needles required. keep reading

What do prostate cancer and heart disease share? More than most men realize. Both are fueled by poor lifestyle habits that create a disease-fostering environment in the body — but both can also be fought with the same powerful tool. Research on 802 cancer survivors points to the Mediterranean Diet as a key ally in long-term survival. keep reading

Your gut is home to trillions of bacteria that do far more than help with digestion. New research suggests an imbalanced gut microbiome, driven by diet, may quietly raise prostate cancer risk through inflammation and immune system disruption. keep reading

Smoking raises prostate cancer risk by 40–60% — most men know that. But what about the air outside your door? A Canadian study found that two common pollutants, PM2.5 and nitrogen dioxide, are linked to higher PCa risk even in men who've never smoked. And a 2025 European report warns a far broader chemical threat is quietly building. keep reading